1. Home
  2. JBLU vs IMNM Comparison

JBLU vs IMNM Comparison

Compare JBLU & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$4.91

Market Cap

1.5B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$22.32

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JBLU
IMNM
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
JBLU
IMNM
Price
$4.91
$22.32
Analyst Decision
Sell
Strong Buy
Analyst Count
9
9
Target Price
$4.76
$26.89
AVG Volume (30 Days)
16.9M
1.2M
Earning Date
01-27-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,095,000,000.00
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.25
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$5.15
52 Week High
$8.31
$20.80

Technical Indicators

Market Signals
Indicator
JBLU
IMNM
Relative Strength Index (RSI) 61.63 68.39
Support Level $4.67 $18.81
Resistance Level $5.15 $20.80
Average True Range (ATR) 0.22 1.45
MACD 0.05 0.12
Stochastic Oscillator 74.74 64.90

Price Performance

Historical Comparison
JBLU
IMNM

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: